GlassScriptPhysician profile
Joseph A Wasselle
NPI 1245295898
$161,369.70
in general payments reported to CMS, 2019-2025
20 companies · $41K in 2025
The $41K reported for 2025 was more than what 97% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53K · 2020: $15K · 2021: $3,241 · 2022: $13K · 2023: $18K · 2024: $17K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $31K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Travel and Lodging: $13K · Food and Beverage: $4,367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $31,400.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28,287.50 |
| Travel and Lodging | $12,520.19 |
| Food and Beverage | $4,367.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $68,322.77 | 2019-2020 | |
| Medtronic, INC. | $44,512.27 | 2021-2025 | Pivox Oblique Lateral Spinal System, Divergence-L Anterior/Oblique Lumbar Fusion System, Divergence Anterior Cervical Fusion System |
| Globus Medical, INC. | $31,273.73 | 2023-2025 | Alif, Elsa, Excelsiusgps Robotic Navigation System |
| 4web, INC. | $14,366.90 | 2022-2024 | Spine Truss System |
| W. L. Gore & Associates, INC. | $593.61 | 2020-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Acuseal Vascular Graft, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Abbott Laboratories | $485.03 | 2024-2025 | Esprit, Diamondback Peripheral, Supera |
| Cook Medical LLC | $427.39 | 2023-2025 | Zilver Ptx, Zenith Spiral-Z, Zenith Alpha |
| Silk Road Medical, INC. | $299.17 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Stryker Corporation | $200.22 | 2022-2023 | Xia 3 |
| Depuy Synthes Sales INC. | $169.33 | 2022 | |
| Davol INC. | $163.43 | 2019-2024 | Arista Ah Flexitip |
| Medical Device Business Services, INC. | $154.00 | 2022-2023 | Conduit |
| Boston Scientific Corporation | $141.38 | 2025 | Enroute Transcarotid Neuroprotection System |
| Endologix LLC | $131.70 | 2024 | Alto Abdominal Stent Graft System |
| Cordis US Corp. | $54.42 | 2024 | Mynx Control |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $19.06 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Pacira Pharmaceuticals Incorporated | $16.41 | 2025 | Exparel |
| Tei Biosciences INC | $15.19 | 2019 | |
| Shockwave Medical, INC | $13.70 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $9.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Wasselle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.